1. Home
  2. Labeler Index
  3. Recordati Rare Diseases
  4. 52276-312
  5. NDC Package Code: 52276-312-05 Carbaglu

NDC Package 52276-312-05 Carbaglu

Carglumic Acid Tablet, For Suspension Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
52276-312-05
Package Description:
5 TABLET, FOR SUSPENSION in 1 BOTTLE
Product Code:
52276-312
Proprietary Name:
Carbaglu
Non-Proprietary Name:
Carglumic Acid
Substance Name:
Carglumic Acid
Usage Information:
None
11-Digit NDC Billing Format:
52276031205
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
5 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 905390 - carglumic acid 200 MG Tablet for Oral Suspension
  • RxCUI: 905390 - carglumic acid 200 MG Dispersible Tablet for Oral Suspension
  • RxCUI: 905394 - Carbaglu 200 MG Tablet for Oral Suspension
  • RxCUI: 905394 - carglumic acid 200 MG Tablet for Oral Suspension [Carbaglu]
  • RxCUI: 905394 - Carbaglu 200 MG Dispersible Tablet for Oral Suspension
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Recordati Rare Diseases
    Dosage Form:
    Tablet, For Suspension - A tablet that forms a suspension when placed in a liquid (formerly referred to as a ‘dispersible tablet’).
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
    • Active Ingredient(s):
  • CARGLUMIC ACID 200 mg/1
    • Pharmacologic Class(es):
  • Carbamoyl Phosphate Synthetase 1 Activator - [EPC] (Established Pharmacologic Class)
  • Carbamoyl Phosphate Synthetase 1 Activators - [MoA] (Mechanism of Action)
    • Sample Package:
    No
    FDA Application Number:
    NDA022562
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    03-18-2010
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    52276-312-6060 TABLET, FOR SUSPENSION in 1 BOTTLE

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 52276-312-05?

    The NDC Packaged Code 52276-312-05 is assigned to a package of 5 tablet, for suspension in 1 bottle of Carbaglu, a human prescription drug labeled by Recordati Rare Diseases. The product's dosage form is tablet, for suspension and is administered via oral form.This product is billed for "EA" each discreet unit and contains an estimated amount of 5 billable units per package.

    Is NDC 52276-312 included in the NDC Directory?

    Yes, Carbaglu with product code 52276-312 is active and included in the NDC Directory. The product was first marketed by Recordati Rare Diseases on March 18, 2010 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 52276-312-05?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 5.

    What is the 11-digit format for NDC 52276-312-05?

    The 11-digit format is 52276031205. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-252276-312-055-4-252276-0312-05